Summary
The product CUTBLEND UNIQUE 300MG/ML, manufactured by Unique Pharma, was independently tested to verify its authenticity and potency. The sample, identified by batch number UN56429, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of the following compounds:
- Drostanolone Propionate: 108.47 mg/ml
- Trenbolone Acetate: 105.00 mg/ml
- Testosterone Propionate: 103.70 mg/ml
The combined concentration totals 317.17 mg/ml, exceeding the labeled claim of 300 mg/ml by 5.72%, indicating slight overdosing.
The testing process commenced on 16 August 2024, with the sample received on 22 August 2024, and the analysis completed on 23 August 2024. While the results confirm accurate dosing with minor variance, it is essential to note that reseller-submitted samples might represent higher-quality batches that do not necessarily reflect overall market consistency. Independent third-party testing remains crucial for comprehensive validation. This report is provided for educational purposes to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: CUTBLEND UNIQUE 300MG/ML
- Active Ingredients:
- Drostanolone Propionate
- Trenbolone Acetate
- Testosterone Propionate
- Batch Number: UN56429
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #47870
- Testing Ordered: 16 August 2024
- Sample Received: 22 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 300 mg/ml (as stated on the label)
- Measured Concentration:
- Drostanolone Propionate: 108.47 mg/ml
- Trenbolone Acetate: 105.00 mg/ml
- Testosterone Propionate: 103.70 mg/ml
- Accuracy:
- Drostanolone Propionate: 108.47%
- Trenbolone Acetate: 105.00%
- Testosterone Propionate: 103.70%
- Variance:
- Drostanolone Propionate: 8.47%
- Trenbolone Acetate: 5.00%
- Testosterone Propionate: 3.70%
Verification Details
- Verification URL: www.janoshik.com/tests/47870_WXITX4RPG49G
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the product’s quality but necessitates careful consideration due to its submission and funding by the reseller Opitropin.EU. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its rigorous testing protocols, further independent testing across multiple batches is recommended for a comprehensive quality assessment.
Conclusion
The analysis of CUTBLEND UNIQUE 300MG/ML confirms a measured concentration of 317.17 mg/ml, indicating an overdose of 5.72% above the label claim. While this suggests good quality control for this batch, it emphasizes the necessity of additional testing to ensure consistent dosing across production batches. This report aims to support educational and harm reduction efforts, enabling consumers to make informed choices.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce inherent biases; however, it still provides useful insights when critically assessed alongside independent third-party results. Readers are encouraged to use this information responsibly.
